Drug recall · May 3, 2023
Fyremadel recall
Why: Presence of Particulate Matter: A piece of glass was found in a prefilled syringe.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Fyremadel (ganirelix acetate) injection, 250 mcg/0.5 mL, One Single Dose Sterile Prefilled Syringe 0.5 mL, For Subcutaneous Use, Rx Only, Sterile, Distributor: Ferring Pharmaceuticals Inc., Parsippany, NJ 07054, USA, NDC 55566-1010-1
- Lots / codes
Lot #: HAD1190A, Exp. 02/2024
- Quantity
- 24194 Prefilled Syringes
- Company
- Sun Pharmaceutical Industries Ltd., Halol, N/A
- Distribution
- Nationwide in the USA
- Initiated
- April 19, 2023 · N/A
- Classified
- May 10, 2023
- Reported
- May 3, 2023
- Ended
- December 13, 2023
- How notified
- N/A
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Fyremadel
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.